Bectumomab, CAS 158318-63-9

Product Description: Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Lamonica D, et al. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL). Cancer Biother Radiopharm. 2002 Dec;17(6):689-97.

CAS Number: 158318-63-9

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD22

• SKU: MEXHY-P99464-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99464-5
• Package Unit: 5mg
• Quantity Unit: STK
• Conjugate: Unconjugated